Umbralisib (TGR-1202) is an orally active, potent and selective dual PI3Kdelta and casein kinase-1-epsilon (CK1epsilon) inhibitor, with EC50 of 22.2 nM and 6.0 µM, respectively. Umbralisib exhibits unique immunomodulatory effects on chronic lymphocytic leukemia (CLL) T
Molecular Weight:
571.55
Purity:
98.69
CAS Number:
[1532533-67-7]
Formula:
C31H24F3N5O3
Target:
Casein Kinase,PI3K
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted